Advertisement
MO BIO
MO BIO

The Scientist

» mice, disease/medicine and microbiology

Most Recent

image: Live-Action Networks

Live-Action Networks

By | October 1, 2012

Mass spec plus novel software equals dynamic views into the chemical lives of microbes.

0 Comments

image: 2012 Labbies Honorable Mentions

2012 Labbies Honorable Mentions

By | October 1, 2012

Check out other memorable images and videos that were submitted to this year’s Labby Multimedia Awards.

0 Comments

image: Medicines for the World

Medicines for the World

By | October 1, 2012

A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.

0 Comments

image: Cystic Fibrosis Alters Microbiome?

Cystic Fibrosis Alters Microbiome?

By | September 28, 2012

The microbiome of the lung is different in patients with the disease, which causes a thick buildup of mucus that makes breathing difficult.

2 Comments

image: Next Generation: Nanowire Forest

Next Generation: Nanowire Forest

By | September 26, 2012

Researchers show that nanowire-based biosensors can collect and detect proteins in one chip.

0 Comments

image: Outbreak Watch

Outbreak Watch

By | September 26, 2012

International health officials are monitoring a new respiratory virus that has killed one person and left another in critical condition.

1 Comment

image: Surviving Acidity

Surviving Acidity

By | September 25, 2012

A new study reveals clues to the naked mole-rat’s ability to thrive in underground environments with high levels of carbon dioxide.

2 Comments

image: Surprise XMRV Retraction

Surprise XMRV Retraction

By | September 21, 2012

The journal PLOS Pathogens abruptly retracts the seminal paper linking XMRV to disease.

2 Comments

image: NIH Clinic Outbreak Kills Again

NIH Clinic Outbreak Kills Again

By | September 20, 2012

A seventh patient succumbs to a deadly, drug-resistant superbug terrorizing the National Institutes of Health Clinical Center.

4 Comments

image: Beating Drug-Resistant TB

Beating Drug-Resistant TB

By | September 19, 2012

Reinvestigating a natural antibiotic compound reveals its potential as a tuberculosis drug.

1 Comment

Advertisement
Lonza
Lonza

Popular Now

  1. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  2. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Biologist Resigns Amid Sexual Misconduct Probe
Advertisement
Advertisement
Life Technologies